Tyson Foods reports a continued decline in beef sales as the U.S. cattle herd hits a 70-year low. While the recent closure of a Nebraska facility has not yet impacted volumes, the meatpacking giant warns of tight supplies through 2027, pivoting to chicken and pork to meet protein demand.
Despite a double-digit decline in 2026, SoFi Technologies continues to post explosive growth. We examine whether the current dip below $25 presents a strategic entry point or a warning sign for investors.
European software, data analytics, and advertising shares tumbled on Tuesday as the rapid evolution of AI models, including new legal-focused tools, sparked investor fears over the durability of established business models. The sell-off highlights a dramatic shift in sentiment toward sectors once considered prime AI beneficiaries.
Aerospace and defense supplier TransDigm Group Inc. (NYSE:TDG) reported robust fourth-quarter results, with revenue climbing 13.9% year-over-year to $2.29 billion, surpassing analyst expectations. The company's strong performance and optimistic full-year outlook underscore its entrenched position in a recovering commercial and resilient defense aviation market.
BellRing Brands (NYSE: BRBR) reported fourth-quarter revenue that surpassed analyst expectations, though sales remained flat year-over-year. The company's full-year outlook and adjusted earnings also topped consensus forecasts, painting a picture of resilient performance amid a challenging market for consumer staples.
Pharmaceutical giant Merck & Co. reported fourth-quarter revenue that surpassed Wall Street forecasts, driven by robust demand for its key products. However, a more conservative full-year sales projection and a sharp expected decline in earnings for the coming year tempered the positive results, sending shares lower in after-hours trading.
Packaging giant Ball Corporation (NYSE: BALL) delivered a robust fourth-quarter performance for 2025, surpassing revenue and profit expectations. The company's focus on operational discipline and shareholder returns, including $1.54 billion in buybacks and dividends, capped a record year.
Despite a strong 52-week performance and a key new partnership with Worldpay, Regions Financial's stock is met with a tepid 'Hold' consensus from Wall Street, highlighting the complex sentiment surrounding regional banks.
Major German business associations are urging parliament and the government to suspend the national Supply Chain Due Diligence Act, arguing recent amendments fail to provide real relief and threaten competitiveness ahead of stricter EU rules.
Despite a recent $1.5 billion capital raise sparking acquisition speculation, SoFi's leadership indicates a disciplined approach to deals, prioritizing organic growth and strategic product expansion over costly buyouts.
An analysis of the German beverage company's financial metrics reveals flat returns on capital and limited reinvestment, casting doubt on its potential for high growth despite a rising stock price.
Amazon Web Services warns that multi-year delays in securing power grid connections are jeopardizing its data center investments across Europe, highlighting a critical infrastructure bottleneck for the continent's digital and industrial ambitions.
CNBC's Jim Cramer pushes back against recent skepticism surrounding Amazon, arguing the market is overlooking the tech giant's fundamental resilience and diversified growth engines.
After years of losses, Evolent Health has broken into profitability with a rising capital base. While its Return on Capital Employed (ROCE) remains low, the accelerating trend suggests a potential inflection point for the healthcare services firm.
Pfizer's shares have staged a notable rebound in recent months, drawing investor attention as the company pivots towards oncology. We examine whether the current valuation reflects its long-term growth potential or lingering post-pandemic challenges.
Aquestive Therapeutics faces a regulatory delay for its sublingual epinephrine film, Anaphylm, after the FDA raised concerns primarily about its packaging and labeling. The company views the issues as solvable and is moving forward with redesigns and new studies, aiming for a 2026 resubmission while advancing parallel filings abroad.
Nike is consolidating its outdoor ambitions, merging its ACG and trail running lines into a dedicated performance brand. The strategic pivot targets a lucrative market as the sportswear giant seeks to reinvigorate growth against a backdrop of a multi-year stock decline.
Following its annual results showing $5 billion in revenue, Antero Resources (AR) faces a valuation conundrum as its share price weakens. While long-term returns remain stellar, recent momentum has cooled, raising questions about its fair value in a shifting energy landscape.
Biosimilars developer Alvotech (NASDAQ: ALVO) presents a complex picture for investors, with recent short-term share price gains starkly contrasted by a punishing 57% decline over the past year. As the stock trades at a significant discount to some analyst targets, the market debates whether this signals a prime opportunity or reflects deeper, unresolved challenges.
A series of class action lawsuits alleging misleading statements about the progress of Ramaco Resources' Brook Mine project has cast a shadow over the company's disclosure practices and market valuation, shifting investor focus from operational metrics to governance credibility.
